Although acute CD8+ T-cell responses to VP2121–130 comprise up to 70% of the central nervous system infiltrating lymphocyte (CNS-IL) pool of CD8+ T-cells, little is known about the development of brain-specific TRM after infection with this virus. The gene discussed is CD8A; the disease is infection.